Publicaciones en colaboración con investigadores/as de University of Western Ontario (105)

2024

  1. BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally

    British Journal of Surgery, Vol. 111, Núm. 2

  2. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

  3. Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta-analysis of randomized controlled trials

    United European Gastroenterology Journal, Vol. 12, Núm. 7, pp. 960-981

  4. Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA

    Hepatology (Baltimore, Md.), Vol. 79, Núm. 6, pp. 1279-1292

  5. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

  6. Frequency and Longitudinal Course of Behavioral and Neuropsychiatric Symptoms in Participants with Genetic Frontotemporal Dementia

    Neurology, Vol. 103, Núm. 8

  7. Frontoparietal network integrity supports cognitive function in pre-symptomatic frontotemporal dementia: Multimodal analysis of brain function, structure, and perfusion

    Alzheimer's and Dementia

  8. Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study

    Brain Communications, Vol. 6, Núm. 4

  9. Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia − A GENFI study

    Brain, Behavior, and Immunity, Vol. 122, pp. 231-240

  10. Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study

    Journal of Alzheimer's Disease, Vol. 100, Núm. s1, pp. S187-S196

  11. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

  12. NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: A large GENFI study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 95, Núm. 9, pp. 822-828

2023

  1. A genetic history of the Balkans from Roman frontier to Slavic migrations

    Cell, Vol. 186, Núm. 25, pp. 5472-5485.e9

  2. Altered plasma protein profiles in genetic FTD – a GENFI study

    Molecular Neurodegeneration, Vol. 18, Núm. 1

  3. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

    Human Brain Mapping, Vol. 44, Núm. 7, pp. 2684-2700

  4. Chronic rhinosinusitis with nasal polyps management in the biologic therapy era: an international YO-IFOS survey

    European Archives of Oto-Rhino-Laryngology, Vol. 280, Núm. 5, pp. 2309-2316

  5. Clinical Manifestations

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 19, pp. e076190

  6. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

    Neurobiology of Disease, Vol. 179

  7. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  8. Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: Comparison with sporadic primary progressive aphasia

    Brain Communications, Vol. 5, Núm. 2